HealthEquity, Inc. (NASDAQ:HQY) Shares Bought by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. raised its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 7,983.6% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 24,655 shares of the company's stock after buying an additional 24,350 shares during the period. Mirae Asset Global Investments Co. Ltd.'s holdings in HealthEquity were worth $2,179,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Versant Capital Management Inc purchased a new stake in HealthEquity during the 1st quarter worth approximately $28,000. Transce3nd LLC acquired a new position in shares of HealthEquity during the 4th quarter worth approximately $29,000. Smartleaf Asset Management LLC boosted its holdings in shares of HealthEquity by 34.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after purchasing an additional 98 shares during the last quarter. Proficio Capital Partners LLC acquired a new position in shares of HealthEquity during the 4th quarter worth approximately $39,000. Finally, Skandinaviska Enskilda Banken AB publ boosted its holdings in shares of HealthEquity by 1,934.8% during the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock worth $45,000 after purchasing an additional 445 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.

Insider Activity

In other news, Director Jon Kessler sold 97,767 shares of the stock in a transaction on Friday, June 6th. The stock was sold at an average price of $112.05, for a total value of $10,954,792.35. Following the sale, the director directly owned 75,000 shares in the company, valued at approximately $8,403,750. This trade represents a 56.59% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Elimelech Rosner sold 58,000 shares of the stock in a transaction on Friday, June 6th. The shares were sold at an average price of $112.56, for a total value of $6,528,480.00. Following the completion of the sale, the executive vice president owned 75,689 shares in the company, valued at approximately $8,519,553.84. The trade was a 43.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 295,700 shares of company stock worth $32,968,990. Corporate insiders own 1.50% of the company's stock.

HealthEquity Trading Down 0.3%

NASDAQ:HQY traded down $0.33 during trading hours on Monday, reaching $101.83. 877,726 shares of the stock were exchanged, compared to its average volume of 863,019. The company has a quick ratio of 4.06, a current ratio of 4.06 and a debt-to-equity ratio of 0.50. The business has a 50-day moving average of $100.09 and a two-hundred day moving average of $98.36. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $116.65. The company has a market capitalization of $8.81 billion, a price-to-earnings ratio of 74.33, a PEG ratio of 1.57 and a beta of 0.49.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.16. The business had revenue of $330.80 million for the quarter, compared to analysts' expectations of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. During the same period last year, the firm earned $0.80 earnings per share. On average, equities analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current year.

Analysts Set New Price Targets

Several brokerages have recently weighed in on HQY. Bank of America boosted their target price on HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a report on Wednesday, June 4th. Barrington Research boosted their target price on HealthEquity from $112.00 to $125.00 and gave the stock an "outperform" rating in a report on Thursday, June 5th. Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a report on Friday, June 6th. The Goldman Sachs Group upped their price objective on HealthEquity from $94.00 to $104.00 and gave the company a "neutral" rating in a report on Wednesday, June 4th. Finally, Royal Bank Of Canada upped their price objective on HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a report on Wednesday, June 4th. One investment analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, HealthEquity presently has an average rating of "Buy" and an average price target of $118.09.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.